ANIK
Anika Therapeutics Inc
20.80$
-1.0%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -11.9% | +11.2% | +9.7% | -6.9% | +8.6% | +13.8% | +13.3% | +5.7% | -22.7% | -0.7% | -5.9% | |
| – | +0.6% | +14.1% | +13.9% | +14.3% | -8.1% | +113.7% | +5.6% | -3.4% | -38.9% | +14.8% | +11.6% | |
| – | -15.0% | +10.3% | +8.4% | -13.7% | +15.6% | -19.6% | +20.2% | +12.8% | -11.8% | -7.9% | -16.0% | |
| – | +10.3% | +19.4% | +75.1% | -3.2% | -8.4% | +40.6% | +16.6% | +3.1% | -22.8% | +17.4% | +0.9% | |
| – | -1.6% | +21.5% | +19.6% | +59.4% | +1.8% | +71.9% | -11.8% | +60.0% | +16.2% | -43.6% | -11.6% | |
| – | +2.6% | +20.7% | +40.3% | +30.3% | -1.7% | +88.6% | -17.5% | +40.6% | -27.7% | -0.7% | -7.7% | |
| – | -21.7% | +5.1% | -9.6% | -52.4% | +57.5% | -182.7% | – | -841.9% | – | -704.4% | – | |
| – | +106.4% | +119.2% | +79.8% | +208.2% | +439.4% | -89.8% | -76.5% | +247.9% | +253.5% | +1.1% | -25.4% | |
| – | -21.5% | +5.4% | -9.2% | -49.8% | +55.6% | -179.2% | – | -872.4% | – | -187.6% | – | |
| – | -24.5% | +4.7% | -21.5% | -68.8% | +99.1% | -152.0% | – | – | – | -8.1% | -88.9% | |
| – | -19.7% | +5.8% | -2.2% | -41.2% | +45.2% | -188.2% | – | -459.4% | – | – | – | |
| – | -21.5% | +4.7% | -8.0% | -44.7% | +45.5% | -102.5% | – | – | – | -69.2% | -166.8% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.